Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOryx International Growth Regulatory News (OIG)

Share Price Information for Oryx International Growth (OIG)

Share Price is delayed by 15 minutes
Get Live Data
1,280.00    5.00 (0.39%)
Bid:
1,230.00
Ask:
1,305.00
Spread: 75.00 (6.098%)
Market Cap: £179.20m
OIG Live PriceLast checked at - London Stock Exchange

Intraday Oryx International Growth Share Chart

Interim Management Statement

16 Feb 2010 17:00

RNS Number : 2319H
Oryx International Growth Fund Ld
16 February 2010
 



ORYX INTERNATIONAL GROWTH FUND LIMITED

 

INTERIM MANAGEMENT STATEMENT FOR THE QUARTER ENDED 31 DECEMBER 2009

 

Oryx International Growth Fund Limited ("Oryx" or the "Company"), is publishing this Interim Management Statement in accordance with DTR 4.3 of the FSA Handbook.

 

This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 

This interim management statement relates to the period from 1 October 2009 to 31 December 2009, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 

 

Manager's Review

 

The market in smaller companies remains difficult but it is pleasing to report a further uplift in the net asset value over the period. A number of the investments are in discussions to be acquired and this could add further value to the portfolio over the next few months.

 

 

Material Transactions

Since 1 October 2009 the Company purchased for cancellation a total of 300,000 ordinary shares at an average cost of £1.758 per share.

 

 

Material Events

There were no material events during the quarter ended 31 December 2009.

 

 

Report and Accounts

On 26 November 2009, the Company posted its Interim Report for the six months ended 30 September 2009, to Shareholders.

 

 

Financial Highlights

 

 

31 December 2009

30 June 2009

31 March 2009

31 December 2008

 

 

 

 

 

NAV

£2.26

£1.97

£1.75

£1.73

 

 

 

 

 

Mid-market price

185.0p

155.0p

100.0p

118.5p

 

 

 

 

 

FTSE All-Share Index

2760.8

 2172.1

 1984.2

 2209.29

 

 

 

 

 

Twenty Largest Equity Investments at 31 December 2009

 

 

%

RPC Group Plc

8.16

Tenon Group Plc

5.93

Avanti Communications Plc

5.72

BBA Aviation Plc

5.51

Gleeson (M.J.) Group Plc

5.34

Castle Support Services Plc

5.30

Orthoproducts Ltd

5.18

AssetCo Plc

5.09

Augean Plc

5.07

Inspired Gaming Group Plc

4.86

Catalyst Media Group Plc

4.47

Bavaria Industriekapital AG

4.15

Bionostics Holdings Limited

4.03

Quarto Group Inc

3.91

Journey Group Plc

3.89

Chrysalis Group Plc

3.21

Nastor Inv Ltd

2.88

Green CO2 Plc

2.54

Pearl Group Ltd

1.97

Essenden Plc

1.69

 

 

 

 

% of total portfolio

88.90

 

 

 

The financial information for the quarter ended 31 December 2009 contained within this Interim Management Statement has not been audited.

 

By order of the Board

 

 

BNP Paribas Fund Services (Guernsey) Limited, for and on behalf of

Oryx International Growth Fund Limited

as Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGURUPUPUGAQ
Date   Source Headline
1st Jun 20114:27 pmRNSNet Asset Value(s)
27th May 20119:11 amRNSTransaction in Own Shares
18th Apr 201111:30 amRNSHolding(s) in Company
15th Apr 20115:12 pmRNSTransaction in Own Shares
13th Apr 20114:00 pmRNSNet Asset Value(s)
13th Apr 20111:05 pmRNSListing Rule 15.5.1(4)
16th Mar 20116:00 pmRNSNet Asset Value(s)
10th Mar 20112:30 pmRNSHolding(s) in Company
9th Mar 20116:20 pmRNSDirectorate Change
9th Mar 20115:11 pmRNSHolding(s) in Company
9th Mar 20115:10 pmRNSHolding(s) in Company
28th Feb 20114:30 pmRNSNet Asset Value(s)
16th Feb 201110:53 amRNSForm 8.3 - IS Pharma Plc
10th Feb 20114:30 pmRNSInterim Management Statement
1st Feb 201111:30 amRNSNet Asset Value(s)
24th Dec 20109:45 amRNSNet Asset Value(s)
13th Dec 20109:54 amRNSTransaction in Own Shares
3rd Dec 201012:10 pmRNSDirectorate Change
2nd Dec 20104:23 pmRNSNet Asset Value(s)
1st Dec 20105:15 pmRNSPosting of Half Year report
19th Nov 20105:50 pmRNSTransaction in Own Shares
19th Nov 20103:09 pmRNSChange of Financial Adviser and Broker
16th Nov 201010:55 amRNSTransaction in Own Shares
11th Nov 20106:31 pmRNSHalf Yearly Report
21st Oct 20101:20 pmRNSNet Asset Value(s) - Replacement
21st Oct 20101:20 pmRNSNet Asset Value(s) - Replacement
20th Oct 20103:55 pmRNSNet Asset Value(s)
20th Oct 20103:55 pmRNSNet Asset Value(s)
1st Oct 20102:22 pmRNSTransactions in Close Period
30th Sep 20101:12 pmRNSNet Asset Value(s)
23rd Aug 20105:28 pmRNSTransaction in Own Shares
23rd Aug 201010:26 amRNSHolding(s) in Company
20th Aug 201011:17 amRNSResult of AGM
19th Aug 20105:38 pmRNSInterim Management Statement
18th Aug 20103:55 pmRNSNet Asset Value(s)
19th Jul 201010:15 amRNSNet Asset Value(s)
16th Jul 20109:17 amRNSHolding(s) in Company
5th Jul 20103:54 pmRNSCirc re. AGM, proposed waiver and change Articles
25th Jun 20103:48 pmRNSNet Asset Value(s)
23rd Jun 20107:00 amRNSAnnual Financial Report
16th Jun 20104:09 pmRNSTransaction in Own Shares
16th Jun 20104:01 pmRNSHolding(s) in Company
10th Jun 20104:57 pmRNSNet Asset Value(s)
21st Apr 20103:33 pmRNSChange of Auditors
21st Apr 20102:57 pmRNSNet Asset Value(s)
15th Apr 20103:28 pmRNSTransactions in a Closed Period
26th Mar 201011:12 amRNSHolding(s) in Company
26th Mar 20107:00 amRNSHolding(s) in Company
18th Mar 20103:53 pmRNSTransaction in Own Shares
17th Mar 201010:15 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.